This article was originally published in The Tan Sheet
The Senate Appropriations Committee recommends that FDA's Center for Food Safety & Applied Nutrition receive $5.3 mil. in funding for its Adverse Event Report System in fiscal year 2007 - a figure that is $1 mil. higher than the President's budget request, according to a committee report released June 22. The proposed increase may be related to the June 21 introduction of legislation that would make serious adverse event reporting mandatory for dietary supplement firms. The committee "has recommended funding to continue enforcement of the provisions contained in DSHEA," the report adds. "It is the Committee's intent that these funds be prioritized by the agency to step up activities against products that are clearly in violation of DSHEA." The senators also are "concerned" that dietary supplement good manufacturing practices have not yet been released by FDA and "direct" the agency to issue them. The Agriculture Appropriations bill now heads to the full Senate after being passed by the committee...
You may also be interested in...
Letter from department’s general counsel responds to request from the company for a pre-enforcement advisory opinion. Despite the letter, Lilly maintains its ‘limited distribution program is fully consistent with applicable laws and regulations.’
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
India has rolled out draft guidelines for development of vaccines with special focus on COVID-19 vaccines, drawing from those of other regulatory bodies and the WHO. Experts suggest the primary efficacy endpoint of minimum 50% is acceptable given that vaccines against respiratory diseases are difficult to develop though not necessarily enough to snuff out a pandemic.